Complete Dosing Protocols for Ozempic and Wegovy Explained

Written by Adam Maggio | Medically reviewed by Dr. James Whitfield, DO, FACOI

Explore the evidence-based dosing protocols for Ozempic and Wegovy to manage type 2 diabetes and obesity. Learn proper administration, titration, and safety considerations.

Introduction

Ozempic and Wegovy are brand names for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily for type 2 diabetes and obesity management, respectively. While both contain the same active ingredient, their dosing regimens differ based on the approved indications and treatment goals. This article provides detailed dosing protocols, practical guidelines, and safety considerations for using Ozempic and Wegovy.

---

Understanding Ozempic and Wegovy

What is Semaglutide?

Semaglutide, a long-acting GLP-1 receptor agonist, helps regulate blood glucose by enhancing insulin secretion, suppressing glucagon, and slowing gastric emptying. It also promotes satiety, making it effective for weight loss.

Indications

  • Ozempic: Approved mainly for glycemic control in adults with type 2 diabetes. It also has cardiovascular benefits.
  • Wegovy: FDA-approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition (e.g., hypertension, type 2 diabetes).

    • ---

    Dosing Protocol for Ozempic

    Starting Dose

  • 0.25 mg once weekly

    • This initial low dose is for 4 weeks and is not intended for glycemic control but to reduce gastrointestinal side effects.

    Dose Escalation

  • After 4 weeks, increase to 0.5 mg once weekly.
  • If additional glycemic control is needed after at least 4 weeks on 0.5 mg, the dose can be increased to 1 mg once weekly.
  • Recently, a 2 mg once weekly dose is also available for enhanced glycemic control.

    • Administration

  • Inject subcutaneously in the abdomen, thigh, or upper arm.
  • Can be administered any time of day, with or without meals.
  • Should be injected on the same day each week.

    • Special Considerations

  • If a dose is missed by more than 5 days, skip it and resume next scheduled dose.
  • Monitor blood glucose regularly.

    • ---

    Dosing Protocol for Wegovy

    Starting Dose and Titration

    Wegovy dosing is designed to gradually increase the semaglutide dose to minimize GI side effects.

  • Week 1-4: 0.25 mg once weekly
  • Week 5-8: 0.5 mg once weekly
  • Week 9-12: 1 mg once weekly
  • Week 13-16: 1.7 mg once weekly
  • Week 17 and onwards: 2.4 mg once weekly (maintenance dose)

    • Administration

  • Subcutaneous injection, preferably rotating injection sites.
  • Inject on the same day each week.

    • Important Notes

  • If dose escalation is not tolerated, maintain the dose for an additional 4 weeks before attempting to increase.
  • Missing a dose by more than 2 days requires resuming at the previous tolerated dose.
  • Weight loss effects may take several weeks to manifest.

    • ---

    Safety and Side Effects

  • Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal pain.
  • Gradual dose escalation helps minimize GI discomfort.
  • Monitor for signs of pancreatitis and severe allergic reactions.
  • Not recommended for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

    • ---

    Practical Tips for Patients

  • Store pens in the refrigerator before first use; after first use, store at room temperature for up to 56 days.
  • Always use a new needle for each injection.
  • Report persistent side effects to your healthcare provider.

    • ---

    Consultation with Healthcare Providers

    Both Ozempic and Wegovy require prescription and medical supervision. It is crucial to consult a healthcare provider to determine the most appropriate dosing protocol based on individual medical history, treatment goals, and potential drug interactions.

    ---

    Conclusion

    Ozempic and Wegovy offer effective options for managing type 2 diabetes and obesity through GLP-1 receptor agonism. Their dosing protocols differ to optimize safety and efficacy for their specific indications. Following prescribed titration schedules and regular medical consultation ensures maximal benefit while minimizing adverse effects. Patients should adhere strictly to dosing instructions and maintain open communication with their healthcare team.